Tonix presents Phase 1 data for Lyme disease candidate TNX-4800, targets Phase 2 trial in H1 2027
Filed May 15, 2026 · Period ending May 15, 2026 · ~1 min read
3 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade TNXP commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 1, 2026 4:00 PM